AnnouncedFiled 27 March 2026
NGM Bio Holdings, Inc. has sold $142M so far
NGM Bio Holdings, Inc., a biotech company based in South San Francisco, CA, has sold $142M so far in its equity round, according to a filing dated 27 March 2026.
Announced on 17 July 2024, 618 days before the filing. ngmbio.com ↗
- Filed
- 27 March 2026
- First filed
- 17 July 2024
- Round
- Equity round (amended filing)
- Amount sold
- $142M
- Offering size
- $142M
- Investors so far
- 26
- Based in
- South San Francisco, CA
- Industry
- Biotech
- Website
- ngmbio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 94% of the 845 tracked raises with an amount filed in 2026, and than 97% of the 78 in biotech.
NGM Bio Holdings, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 27 Mar 2026 | Amended filing | $142M | This raise |
| 17 Jul 2024 | New filing | $73.2M | This raise |
More with Column on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.